Evaluate Pharma reports that the market for
prescription drugs, based on the consensus forecast for the leading 500
pharmaceutical and biotechnology companies, will grow by 5.1% per year (CAGR)
to reach $1,017 bn. by 2020. Worldwide prescription growth was an uninspiring
0.3% in 2013, close to the 0.4% predicted in the previous edition of the World
Preview report. This represents a return to modest growth versus the 1.6%
contraction in 2012. The depreciation of the yen against the dollar has
negatively impacted Japan's contribution to the worldwide market in 2013 by
around $15bn. Sales at risk from patent expiries will average $3bn. per year to
2020; however, as an increasing proportion of sales are from biological
products, the predicted erosion post-expiration is expected to be softer, thus
protecting industry growth.
Worldwide Prescription Drug Sales in
2020: Top 20 Companies
1 Novartis 2 Roche 3 Sanofi 4 Pfizer
5 GlaxoSmithKline 6 Merck & Co.
7 Johnson & Johnson 8
AstraZeneca 9 Novo Nordisk 10 Gilead Sciences
11 AbbVie 12 Bayer 13 Bristol-Myers Squibb 14 Amgen 15
Takeda
16 Eli Lilly 17 Boehringer
Ingelheim 18 Teva Pharmaceutical Industries
19 Astellas Pharma 20 Biogen Idec
If keywords like clinical research training institute in Hyderabad or clinical SAS training institutes in Hyderabad have brought you here, this post is for you.
ReplyDelete